Leerink Partnrs Predicts Weaker Earnings for Quanterix

Quanterix Co. (NASDAQ:QTRX - Free Report) - Analysts at Leerink Partnrs lowered their FY2024 EPS estimates for Quanterix in a note issued to investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings per share of ($0.98) for the year, down from their prior estimate of ($0.94). The consensus estimate for Quanterix's current full-year earnings is ($0.94) per share. Leerink Partnrs also issued estimates for Quanterix's Q4 2024 earnings at ($0.27) EPS, Q1 2025 earnings at ($0.58) EPS, Q2 2025 earnings at ($0.26) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($1.33) EPS and FY2026 earnings at ($0.89) EPS.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings data on Monday, December 23rd. The company reported ($0.22) earnings per share for the quarter. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%.

Separately, TD Cowen boosted their price objective on shares of Quanterix from $13.50 to $16.00 and gave the company a "hold" rating in a research report on Wednesday, November 13th.

Quanterix Stock Up 1.6 %

QTRX stock traded up $0.17 during trading on Thursday, hitting $10.19. 729,120 shares of the company's stock traded hands, compared to its average volume of 1,082,792. The stock has a market capitalization of $392.33 million, a price-to-earnings ratio of -9.63 and a beta of 1.33. Quanterix has a 52 week low of $8.21 and a 52 week high of $29.70. The stock has a fifty day moving average price of $11.02 and a two-hundred day moving average price of $12.46.

Institutional Investors Weigh In On Quanterix

Several large investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. grew its position in shares of Quanterix by 14.5% during the second quarter. American Century Companies Inc. now owns 56,145 shares of the company's stock worth $742,000 after acquiring an additional 7,118 shares during the last quarter. Envestnet Asset Management Inc. grew its position in Quanterix by 2,261.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 209,731 shares of the company's stock worth $2,771,000 after purchasing an additional 200,851 shares during the last quarter. Hsbc Holdings PLC increased its stake in shares of Quanterix by 34.7% in the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company's stock valued at $164,000 after purchasing an additional 3,279 shares during the period. XTX Topco Ltd bought a new stake in shares of Quanterix during the second quarter valued at approximately $307,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Quanterix during the second quarter worth approximately $140,000. 86.48% of the stock is owned by institutional investors and hedge funds.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.